Pila Pharma AB (FRA:5KC) Days Payable: 0.00 (As of Dec. 2025)


FRA:5KC Pila Pharma AB FRA:5KC
49 GF Score
Price €0.10
GF Value €0.15
! 3 Warning Signs
View Full Analysis

What is Pila Pharma AB Days Payable?

Pila Pharma AB FRA:5KC -3.24% 49 Days Payable is 0.00 as of Dec. 2025. GuruFocus rates FRA:5KC with a GF Score™ of 49/100 and a GF Value™ of €0.15. The stock has 3 warning signs investors should review. Among 702 Biotechnology companies, Pila Pharma AB ranks worse than 142450% on this metric.

Pila Pharma AB's average Accounts Payable for the six months ended in Dec. 2025 was €0.02 Mil. Pila Pharma AB's Cost of Goods Sold for the six months ended in Dec. 2025 was €0.00 Mil.

The historical rank and industry rank for Pila Pharma AB's Days Payable or its related term are showing as below:

During the past 8 years, Pila Pharma AB's highest Days Payable was 2727.89. The lowest was 49.08. And the median was 91.75.

FRA:5KC's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 113.1
* Ranked among companies with meaningful Days Payable only.

Pila Pharma AB's Days Payable stayed the same from Dec. 2024 (0.00) to Dec. 2025 (0.00).

Pila Pharma AB Days Payable Historical Data

* Premium members only.

The historical data trend for Pila Pharma AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pila Pharma AB Days Payable Chart

Pila Pharma AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial 2,509.38 0.00 0.00 0.00 0.00

Pila Pharma AB Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:5KC vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Pila Pharma AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pila Pharma AB Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pila Pharma AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Pila Pharma AB's Days Payable falls into.


FRA:5KC
49GF Score
Pila Pharma AB FRA:5KC
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pila Pharma AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Pila Pharma AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0.039 + 0.021) / 2 ) / 0*365
=0.03 / 0*365
=N/A

Pila Pharma AB's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (0.013 + 0.021) / 2 ) / 0*365 / 2
=0.017 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Pila Pharma AB (FRA:5KC) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pila Pharma AB and its competitors. Over the past decade, Pila Pharma AB's Days Payable has ranged from 49.08 to 2,727.89. According to the industry distribution chart, Pila Pharma AB ranks #999999 out of 702 companies in the Biotechnology industry.
Is Pila Pharma AB's Days Payable too high?
Pila Pharma AB's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 49.08 to a high of 2,727.89. Based on the distribution chart, Pila Pharma AB ranks #999999 out of 702 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Pila Pharma AB has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Pila Pharma AB's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Pila Pharma AB ranks #999999 out of 702 companies for Days Payable. This places Pila Pharma AB in the lower half of its industry. The industry median Days Payable is 113.10. Historically, Pila Pharma AB's own Days Payable has ranged from 49.08 to 2,727.89 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.10, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pila Pharma AB and its competitors. For the Biotechnology industry, the median Days Payable is 113.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pila Pharma AB's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pila Pharma AB stock overvalued right now?
Pila Pharma AB (FRA:5KC) has a current Days Payable of 0.00. The stock's GF Value™ is €0.15, compared to a current price of €0.10 — trading 30.3% below its estimated fair value. The current Days Payable is 0.00. Pila Pharma AB's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Pila Pharma AB (FRA:5KC), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pila Pharma AB (FRA:5KC) Overvalued in 2026?

Based on GuruFocus' analysis, Pila Pharma AB stock appears to be undervalued. The current stock price of €0.10 is trading 30.3% below its estimated GF Value™ of €0.15.

Key valuation signals for FRA:5KC:

  • Days Payable: 0.00
  • GF Value™: €0.15 vs. price of €0.10 (30.3% below fair value)
  • GF Score™: 49/100 with 3 warning signs

No single metric tells the full story. See the FRA:5KC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pila Pharma AB Business Description

Other Exchanges PILA:Sweden
Address Norra Vallgatan 72, Malmo, SWE, 211 21
Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.
49GF Score

Get the complete analysis for FRA:5KC

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.15
GF Value